Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma.

Wu CS, Yen CJ, Chou RH, Li ST, Huang WC, Ren CT, Wu CY, Yu YL.

PLoS One. 2012;7(7):e39466. doi: 10.1371/journal.pone.0039466. Epub 2012 Jul 13.

2.

Natural history of chronic hepatitis B REVEALed.

Chen CJ, Yang HI.

J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. Review.

PMID:
21323729
3.

Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.

Bertino G, Neri S, Bruno CM, Ardiri AM, Calvagno GS, Malaguarnera M, Toro A, Malaguarnera M, Clementi S, Bertino N, Di Carlo I.

Minerva Med. 2011 Oct;102(5):363-71. Review.

PMID:
22193346
4.

Markers for hepatocellular carcinoma.

Wu AH, Sell S.

Immunol Ser. 1990;53:403-22. Review.

PMID:
1713067
5.

[Screening for hepatocellular carcinoma].

Leone N, Rizzetto M.

Minerva Med. 2005 Apr;96(2):95-108. Review. Italian.

PMID:
16172579
6.

Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?

Montagnana M, Danese E, Lippi G.

Clin Chim Acta. 2015 May 20;445:161-6. doi: 10.1016/j.cca.2015.03.031. Epub 2015 Apr 1. Review.

PMID:
25840050
7.

Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma.

Van Hees S, Michielsen P, Vanwolleghem T.

World J Gastroenterol. 2016 Oct 7;22(37):8271-8282. Review.

8.

Hepatocellular carcinoma tumour markers: current role and expectations.

Rich N, Singal AG.

Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):843-53. doi: 10.1016/j.bpg.2014.07.018. Epub 2014 Aug 22. Review.

PMID:
25260312
9.

Biomarkers for virus-induced hepatocellular carcinoma (HCC).

Mathew S, Ali A, Abdel-Hafiz H, Fatima K, Suhail M, Archunan G, Begum N, Jahangir S, Ilyas M, Chaudhary AG, Al Qahtani M, Mohamad Bazarah S, Qadri I.

Infect Genet Evol. 2014 Aug;26:327-39. doi: 10.1016/j.meegid.2014.06.014. Epub 2014 Jun 21. Review.

PMID:
24956436
10.

Contribution of biomarkers and imaging in the management of hepatocellular carcinoma.

Fartoux L, Decaens T.

Clin Res Hepatol Gastroenterol. 2011 Jun;35 Suppl 1:S21-30. doi: 10.1016/S2210-7401(11)70004-3. Review.

PMID:
21742297
11.
12.

Proteomic analysis of HBV-associated HCC: insights on mechanisms of disease onset and biomarker discovery.

Niu D, Feng H, Chen WN.

J Proteomics. 2010 May 7;73(7):1283-90. doi: 10.1016/j.jprot.2010.02.016. Epub 2010 Feb 24. Review.

PMID:
20188222
13.

Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors.

Zhang JY, Tan EM.

Expert Rev Mol Diagn. 2010 Apr;10(3):321-8. doi: 10.1586/erm.10.12. Review.

14.

Potential applications of miRNAs as diagnostic and prognostic markers in liver cancer.

Gailhouste L, Gomez-Santos L, Ochiya T.

Front Biosci (Landmark Ed). 2013 Jan 1;18:199-223. Review.

PMID:
23276918
15.

Screening and detection of hepatocellular carcinoma.

Simpson HN, McGuire BM.

Clin Liver Dis. 2015 May;19(2):295-307. doi: 10.1016/j.cld.2015.01.004. Epub 2015 Feb 28. Review.

PMID:
25921664
16.

A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma.

Steel LF, Mattu TS, Mehta A, Hebestreit H, Dwek R, Evans AA, London WT, Block T.

Dis Markers. 2001;17(3):179-89. Review.

17.

Challenges in cancer vaccine development for hepatocellular carcinoma.

Buonaguro L, Petrizzo A, Tagliamonte M, Tornesello ML, Buonaguro FM.

J Hepatol. 2013 Oct;59(4):897-903. doi: 10.1016/j.jhep.2013.05.031. Epub 2013 May 25. Review. Erratum in: J Hepatol. 2014 Jan;60(1):237.

18.

Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics.

Yang N, Ekanem NR, Sakyi CA, Ray SD.

Adv Drug Deliv Rev. 2015 Jan;81:62-74. doi: 10.1016/j.addr.2014.10.029. Epub 2014 Nov 6. Review.

PMID:
25450260
19.

[Molecular markers of micrometastasis in the blood of hepatocellular carcinoma patients].

Stokowska A, Stalke P, Bielawski KP.

Postepy Hig Med Dosw (Online). 2007 May 18;61:310-9. Review. Polish.

20.

Epidemiology and surveillance of hepatocellular carcinoma.

Kim DY, Han KH.

Liver Cancer. 2012 Jun;1(1):2-14. doi: 10.1159/000339016. Review.

Supplemental Content

Support Center